Cantabio Pharmaceuticals Inc. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2017)

-$2.0M

Total Assets (FY2017)

$109.4K

Total Equity (FY2017)

-$1.9M

Cash Flows from Operating Activities (FY2017)

-$623.3K

Source: Cantabio Pharmaceuticals Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.